Development and Assessment of a Model for Predicting Individualized Outcomes in Patients With Oropharyngeal Cancer
Sign Up to like & getrecommendations! Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.20055
Abstract: Key Points Question Can a model be developed for individualized survival, locoregional recurrence, and distant metastasis prognostication for patients newly diagnosed with oropharyngeal cancer, incorporating clinical, oncologic, and imaging data? Findings In this prognostic study,… read more here.
Keywords: development assessment; assessment model; oropharyngeal cancer; patients oropharyngeal ... See more keywords
Elderly patients diagnosed with hepatopancreatobiliary malignancies: A challenge beyond resection
Sign Up to like & getrecommendations! Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30502
Abstract: staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICONS): a multicentre cohort study. Lancet Oncol. 2016;17:440-451. 13. Haughey BH, Sinha P, Kallogjeri D, et al. Pathology-based staging… read more here.
Keywords: oropharyngeal cancer; hepatopancreatobiliary malignancies; elderly patients; diagnosed hepatopancreatobiliary ... See more keywords
Stage I HPV‐positive oropharyngeal cancer: Should all patients receive similar treatments?
Sign Up to like & getrecommendations! Published in 2019 at "Cancer"
DOI: 10.1002/cncr.32501
Abstract: Patients with clinical stage I human papillomavirus (HPV)–positive oropharyngeal squamous cell cancer (OPSCC) according to the American Joint Committee on Cancer (AJCC) eighth edition classification comprise a heterogeneous group formerly classified as stage I to… read more here.
Keywords: positive oropharyngeal; oropharyngeal cancer; stage hpv; cancer ... See more keywords
Sexual debut and association with oral human papillomavirus infection, persistence and oropharyngeal cancer—An analysis of two Australian cohorts
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Cancer"
DOI: 10.1002/ijc.33986
Abstract: Oropharyngeal cancer is increasingly caused by human papillomavirus (HPV), and this increase is believed to be caused by changing sexual behaviour. It has been hypothesised that an immune response to HPV through sexual intercourse is… read more here.
Keywords: debut; australian cohorts; two australian; oropharyngeal cancer ... See more keywords
Patient‐reported outcomes in human papillomavirus‐related oropharyngeal cancer
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26690
Abstract: This review explores how human papillomavirus‐related oropharyngeal cancer affects health‐related quality of life (HR‐QoL) and the role patient‐reported outcomes (PROs) can play in optimizing treatment. PRO measures (PROMs) are comprehensive, subjective assessments of patients’ day‐to‐day… read more here.
Keywords: reported outcomes; related oropharyngeal; oropharyngeal cancer; papillomavirus related ... See more keywords
Is HPV‐Associated Oropharyngeal Cancer Becoming More Common in Older Patients?
Sign Up to like & getrecommendations! Published in 2018 at "Laryngoscope Investigative Otolaryngology"
DOI: 10.1002/lio2.181
Abstract: To evaluate changing age demographics over a 15‐year period for patients with HPV‐associated oropharyngeal squamous cell carcinoma (OPSCC). read more here.
Keywords: associated oropharyngeal; oropharyngeal cancer; becoming common; patients hpv ... See more keywords
Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer
Sign Up to like & getrecommendations! Published in 2018 at "Dysphagia"
DOI: 10.1007/s00455-018-9913-8
Abstract: The aim of this cross-sectional study is to evaluate the factors associated with patient-reported dysphagia in patients affected by locally advanced oropharyngeal cancer (OPC) treated with definitive intensity-modulated radiation therapy (IMRT) and concurrent chemotherapy (CHT),… read more here.
Keywords: predictors patient; oropharyngeal cancer; reported dysphagia; patient reported ... See more keywords
Artificial Intelligence-Guided Prediction of Dental Doses Before Planning of Radiation Therapy for Oropharyngeal Cancer: Technical Development and Initial Feasibility of Implementation
Sign Up to like & getrecommendations! Published in 2022 at "Advances in Radiation Oncology"
DOI: 10.1016/j.adro.2021.100886
Abstract: Purpose The aim was to develop a novel artificial intelligence (AI)–guided clinical decision support system, to predict radiation doses to subsites of the mandible using diagnostic computed tomography scans acquired before any planning of head… read more here.
Keywords: artificial intelligence; radiation therapy; radiation; intelligence guided ... See more keywords
Functional outcomes and survival of patients with oral and oropharyngeal cancer after total glossectomy.
Sign Up to like & getrecommendations! Published in 2019 at "Brazilian journal of otorhinolaryngology"
DOI: 10.1016/j.bjorl.2019.02.005
Abstract: INTRODUCTION Cancer of the oral cavity and oropharynx exhibits an aggressive behavior and its diagnosis is, in most cases, attained at advanced stages. Total glossectomy is a therapeutic option in locally advanced cancer, and the… read more here.
Keywords: cancer total; patients oral; cancer; oropharyngeal cancer ... See more keywords
De-intensification for HPV positive oropharyngeal cancer: and yet it moves!
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Translational Radiation Oncology"
DOI: 10.1016/j.ctro.2020.03.004
Abstract: Highlights • De-intensification for HPV positive oropharyngeal cancer is a major research topic.• Results of pivotal randomized trials on de-intensification were published in 2019.• Progress in knowledge was achieved through NRG 1016, De-ESCALaTE and ORATOR… read more here.
Keywords: intensification hpv; positive oropharyngeal; oropharyngeal cancer; hpv positive ... See more keywords
Could the endocrine disruptor bisphenol-A be implicated in the pathogenesis of oral and oropharyngeal cancer? Metabolic considerations and future directions.
Sign Up to like & getrecommendations! Published in 2019 at "Metabolism: clinical and experimental"
DOI: 10.1016/j.metabol.2018.11.007
Abstract: Bisphenol-A (BPA), a prototype endocrine disrupting molecule, has been associated with many disease entities such as diabetes mellitus, obesity, polycystic ovarian disease, cardiovascular disease, reproductive and neurodevelopmental disorders. BPA has also been associated mainly with… read more here.
Keywords: bisphenol; oral oropharyngeal; bpa; oropharyngeal cancer ... See more keywords